Adeptus Health Reports Second Quarter 2016 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Needham Starts NeoVolta (NEOV) at Buy
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
Jefferies Cuts Price Target on Adeptus Health (ADPT) Following 2Q Report; Reiterates Buy
July 22, 2016 8:54 AM EDTJefferies maintained a Buy rating on Adeptus Health (NYSE: ADPT), and cut the price target to $100.00 (from $113.00), following the company's 2Q earnings report. Q2 results mostly came in below expectations and at the low end of management's guidance. Jefferies does not expect meaningful... More
Adeptus Health (ADPT) Misses Q2 EPS by 3c
July 21, 2016 6:52 AM EDTAdeptus Health (NYSE: ADPT) reported Q2 EPS of $0.48, $0.03 worse than the analyst estimate of $0.51. Revenue for the quarter came in at $100.2 million versus the consensus estimate of $93.92 million.
2016 Guidance Reaffirmed
We continue to expect systemwide net patient services revenue, which includes revenue... More
